|

Use Repetitive Transcranial Magnetic Stimulation to Treat Somatic Symptom Disorder

RECRUITINGN/ASponsored by National Taiwan University Hospital
Actively Recruiting
PhaseN/A
SponsorNational Taiwan University Hospital
Started2022-08-29
Est. completion2025-12-31
Eligibility
Age20 Years – 70 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05161819

Summary

This is a randomized double-blind sham-controlled crossover study; the interventions are high-frequency rTMS stimulation on left DLPFC and sham control. The study population is the patient with somatic symptom disorder. The primary outcomes are somatic distress and health anxiety.

Eligibility

Age: 20 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patient with somatic symptom disorder (confirmed by psychiatrists)
* Age 20-70

Exclusion Criteria:

* Having psychotic symptoms or cognitive impairment
* Having potentially lethal illness
* Using cardiac pacemakers or defibrillators
* Currently pregnant or having plans to become pregnant within the next three months
* Received rTMS treatment within three months
* Cannot read the questionnaires by oneself
* Having to take the following medications persistently: bupropion \>300 mg/day、TCA、clozapine、chlorpromazine、foscarnet、ganciclovir、ritonavir、theophylline

Conditions2

AnxietySomatic Symptom Disorder

Browse More Trials

Anxiety trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.